Prevalence of clinically actionable hsCRP and implications for statin eligibility and residual ASCVD risk in the United States
30 August 2026 (08:15 - 08:25)
Organised by: 
Abstract
Slides
About the speaker
Mass General Brigham, Boston (United States of America)
5 More presentations in this session
Doctor M. Coriano' (London, GB)
Professor D. Wolf (Freiburg, DE)
Doctor J. Lehmacher (Hamburg, DE)
Professor R. Twerenbold (Hamburg, DE)
Access the full session
The Event
ESC Congress 2026
30 August 2026
08:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Session
Congress Presentation
